Display options
Cite
Nagy G, Czirják L, Kumánovics G. Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities. Diagnostics (Basel). 2021;11(9)doi: 10.3390/diagnostics11091606.
Nagy, G., Czirják, L., & Kumánovics, G. (2021). Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities. Diagnostics (Basel, Switzerland), 11(9), . https://doi.org/10.3390/diagnostics11091606
Nagy, Gabriella, et al. "Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities." Diagnostics (Basel, Switzerland) vol. 11,9 (2021). doi: https://doi.org/10.3390/diagnostics11091606
Nagy G, Czirják L, Kumánovics G. Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities. Diagnostics (Basel). 2021 Sep 03;11(9). doi: 10.3390/diagnostics11091606. PMID: 34573948; PMCID: PMC8468290.
Copy Download .nbib Format: NLM
Share it on

Diagnostics (Basel). 2021 Sep 03;11(9). doi: 10.3390/diagnostics11091606.

Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities.

Diagnostics (Basel, Switzerland)

Gabriella Nagy, László Czirják, Gábor Kumánovics

Affiliations

  1. Department of Rheumatology and Immunology, Medical School, University of Pécs, Akác Street 1, 7362 Pécs, Hungary.

PMID: 34573948 PMCID: PMC8468290 DOI: 10.3390/diagnostics11091606

Abstract

INTRODUCTION: Nailfold video capillaroscopy (NVC) is a useful tool for measuring capillary density (CD) and capillary morphology parameters and is mainly used in systemic sclerosis (SSc).

OBJECTIVE: We aimed to assess the prevalence of an SSc pattern and CD in different connective tissue diseases (CTDs).

METHODS: NVC was performed on 268 patients with CTDs. Control groups consisted of 104 healthy volunteers (HVs) and 36 primary Raynaud's patients (PRPs).

RESULTS: Decreased CD was more prevalent in SSc, systemic lupus erythematosus (SLE), inflammatory myopathies (IIM), and overlap CTD patients compared with both controls. Average CD, the prevalence of decreased CD, and the prevalence of an SSc pattern did not differ significantly between SSc patients with (

CONCLUSION: The presence of another CTD in SSc did not influence CD or morphology. An SSc pattern may also be present in CTDs other than SSc. The MES is a useful instrument to distinguish between patients with CTDs and controls.

Keywords: SSc pattern; capillary density; connective tissue diseases; nailfold video capillaroscopy; systemic sclerosis

References

  1. Ann Rheum Dis. 2015 Apr;74(4):730-7 - PubMed
  2. Int J Rheum Dis. 2020 Aug;23(9):1219-1225 - PubMed
  3. Rheumatology (Oxford). 2018 Apr 1;57(4):757-759 - PubMed
  4. Ann Rheum Dis. 1970 May;29(3):244-53 - PubMed
  5. Arthritis Rheum. 2012 Aug;64(8):2677-86 - PubMed
  6. Arthritis Res Ther. 2020 Oct 13;22(1):237 - PubMed
  7. Ann Rheum Dis. 2010 Jun;69(6):1092-6 - PubMed
  8. Arthritis Rheum. 2003 Nov;48(11):3023-30 - PubMed
  9. Ann Rheum Dis. 2011 Jan;70(1):180-3 - PubMed
  10. Arthritis Rheum. 2009 May 15;61(5):688-94 - PubMed
  11. Clin Exp Rheumatol. 2005 Nov-Dec;23(6):789-94 - PubMed
  12. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87 - PubMed
  13. Semin Arthritis Rheum. 2015 Jun;44(6):680-6 - PubMed
  14. Clin Rheumatol. 2015 Feb;34(2):279-84 - PubMed
  15. Microvasc Res. 2020 Sep;131:104036 - PubMed
  16. Rheumatology (Oxford). 1999 Sep;38(9):826-30 - PubMed
  17. Clin Rheumatol. 2017 Sep;36(9):1969-1974 - PubMed
  18. J Thromb Haemost. 2006 Feb;4(2):295-306 - PubMed
  19. Rheumatology (Oxford). 2007 Oct;46(10):1566-9 - PubMed
  20. Rheumatology (Oxford). 2010 Sep;49(9):1699-705 - PubMed
  21. Rheumatology (Oxford). 2004 Aug;43(8):1025-7 - PubMed
  22. Int J Rheum Dis. 2016 Sep;19(9):913-23 - PubMed
  23. J Rheumatol. 2000 Jan;27(1):155-60 - PubMed
  24. Arthritis Rheumatol. 2016 Oct;68(10):2527-39 - PubMed
  25. J Med Invest. 2021;68(1.2):6-14 - PubMed
  26. Microvasc Res. 2013 Nov;90:90-5 - PubMed
  27. Rheumatol Int. 2013 Apr;33(4):859-65 - PubMed
  28. Acta Reumatol Port. 2016 Jan-Mar;41(1):8-14 - PubMed
  29. Lupus. 2002;11(1):35-41 - PubMed
  30. Arthritis Rheum. 1986 Feb;29(2):189-95 - PubMed
  31. J Autoimmun. 2014 Feb-Mar;48-49:60-5 - PubMed
  32. J Eur Acad Dermatol Venereol. 2004 Jan;18(1):62-8 - PubMed
  33. Autoimmun Rev. 2019 Nov;18(11):102394 - PubMed
  34. Arthritis Rheum. 1997 Sep;40(9):1725 - PubMed
  35. Microvasc Res. 2012 May;83(3):318-22 - PubMed
  36. N Engl J Med. 1975 Feb 13;292(7):344-7 - PubMed
  37. Ann Rheum Dis. 2012 Aug;71(8):1355-60 - PubMed
  38. Clin Rheumatol. 2019 Sep;38(9):2299-2307 - PubMed
  39. Ann Rheum Dis. 2002 Jun;61(6):554-8 - PubMed
  40. Arthritis Rheum. 1980 May;23(5):581-90 - PubMed
  41. Rheumatology (Oxford). 2016 May;55(5):883-90 - PubMed
  42. Rheumatology (Oxford). 2021 Mar 2;60(3):1410-1418 - PubMed
  43. Clin Hemorheol Microcirc. 2015;59(2):133-43 - PubMed
  44. Arthritis Rheum. 2010 Sep;62(9):2569-81 - PubMed
  45. Semin Arthritis Rheum. 2017 Dec;47(3):432-444 - PubMed
  46. J Rheumatol. 2013 Dec;40(12):2023-8 - PubMed
  47. J Clin Rheumatol. 2005 Dec;11(6):295-8 - PubMed
  48. Ann Rheum Dis. 2008 Jun;67(6):885-7 - PubMed
  49. Semin Arthritis Rheum. 2017 Aug;47(1):86-94 - PubMed
  50. Reumatismo. 2013 Oct 31;65(4):186-91 - PubMed
  51. Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):150-157 - PubMed
  52. Ann Rheum Dis. 2013 Nov;72(11):1747-55 - PubMed
  53. Autoimmun Rev. 2018 Apr;17(4):344-352 - PubMed

Publication Types

Grant support